Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
CRANBURY, N.J., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (NASDAQ:FOLD) today announced the pricing of an underwritten offering of 19,354,839 shares of its common stock at $15.50 per share. The gross proceeds …
Johnson & Johnson will pay $2.2 billion to settle charges that the company marketed drugs for unapproved uses and paid "kickbacks" to doctors and nursing homes. The penalties announced Monday involve fines and forfeiture to the federal …
The pharmaceutical and consumer giant was ordered to pay $417 million to Eva Echeverria, 63, who claimed she developed ovarian cancer after using the company's baby powder since she was 11 years old.
Johnson & Johnson, which has lost three straight trials claiming its talc-based products cause ovarian cancer, is seeking to reverse the trend by having the cases heard in a different court. All three awards, totaling around $195 million, were …
HELENA — Montana has joined with 42 other states who reached a $33 million settlement with Johnson & Johnson over selling drugs contaminated with metal. Between 2009 and 2011 Johnson & Johnson announced voluntary recalls of …
LOS ANGELES (AP) — A judge on Friday tossed out a $417 million jury award to a woman who claimed she developed ovarian cancer by using Johnson & Johnson talc-based baby powder for feminine hygiene. Los Angeles County …
KCPQ4mon
A Missouri appeals court on Tuesday that vacated a $72 million US award to an Alabama woman who claimed her use of Johnson & Johnson products that contained talcum contributed to her ovarian cancer has thrown the fate of awards in …
CBC4mon